SEC Form 4 · accession 0001179110-16-027113
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hubert L Allen
Officer — Executive Vice President
Period of report
Jun 28, 2016
Accepted (ET)
Jun 30, 2016 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jun 28, 2016 | M | 3,400 | $20.7485 | A | 91,857 | D | |
| Common shares without par value | Jun 28, 2016 | S | 3,400 | $37.14 | D | 88,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $20.7485 | Jun 28, 2016 | M | 3,400 | D | Jun 30, 2009 | Jun 29, 2016 | Common shares | 3,400 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).